Depression and Anxiety Together: Why They Often Show Up as a Pair

Most people who come in for depression also describe anxiety. Most people who come in for anxiety also describe low mood. This is so consistent that the more useful question is not whether someone has both, but which one they noticed first and which one is causing more trouble right now.

Here is what the research says about why that happens, and what it changes about treatment.

“How common is it, really?”

About 45 percent of people with a lifetime history of major depression have also had an anxiety disorder at some point. Within any given twelve month window, the overlap sits around 42 percent. Coming from the other side, roughly 60 percent of people with an anxiety disorder report depressive symptoms too.

Break it down by specific anxiety disorder and the numbers shift:

Panic disorder, about 50 percent lifetime overlap with depression. PTSD, about 48 percent. Generalized anxiety disorder, about 43 percent. Social anxiety disorder has the widest range across studies, anywhere from 20 to 70 percent depending on the sample.

“Which one comes first?”

Usually anxiety. And usually by a while.

One European study looking at social phobia and major depression found the anxiety came first in 65 percent of cases, typically by two years or more. That same research found an early social phobia presentation multiplied the risk of later major depression by almost six.

So the person who has felt anxious since they were fifteen and depressed since they were thirty is not describing two unrelated things. That is a recognized trajectory.

“Why do they overlap so much?”

Four different explanations, all partially true at once.

Genetics. Both run around 40 percent heritable, and the inherited risk is not specific to either one. What gets passed down is a general vulnerability to this whole family of conditions, which researchers group as the internalizing disorders. A family history of anxiety raises depression risk and vice versa.

Temperament. Neuroticism, meaning a disposition toward strong negative emotional response and heightened stress reactivity, predicts both.

Environment. Early adversity, including trauma and neglect, is a shared risk factor. Same input, two possible outputs, often both.

Neurology. Both conditions involve altered function in the prefrontal and limbic circuits that handle emotional regulation. Same machinery, different malfunction. This is a large part of why treatments built for one condition tend to help the other.

“How do you tell them apart if the symptoms are the same?”

Honestly, several of them you cannot, not from symptoms alone.

Sleep problems belong to both. There is a rough pattern, anxiety tends to make falling asleep hard because the mind will not stop, while depression more often produces early waking or sleep that restores nothing. But plenty of people have both patterns in the same week, so it is not diagnostic.

Concentration trouble, both. Fatigue, both. Irritability, both. Restlessness, both.

Someone who says “I cannot focus, I cannot sleep, I am exhausted” has just described symptoms that fit either condition or both simultaneously. That is exactly why a structured evaluation exists instead of a symptom checklist.

“Does having both make treatment harder?”

Yes, measurably.

Research on anxious depression, meaning depression with significant anxiety alongside it, found these patients are less likely to reach remission than patients with depression alone. They also carry a heavier side effect burden during medication treatment. The combination correlates with more severe symptoms overall, more suicidal ideation, and more impairment at work and in relationships.

That is the difficult part. The other part is that it stays treatable. It takes longer, needs closer follow up, and requires a plan aimed at both conditions instead of one.

Worth knowing about a gap in the evidence, too. Most treatment studies looked at single conditions. The research base for treating both together is thinner than the research base for treating either separately, which is why clinicians often end up layering approaches rather than following one protocol. A common example: medication improves mood, anxiety stays put, so cognitive behavioral therapy gets added on top.

“Can one treatment cover both?”

Often, yes.

SSRIs and SNRIs work across depression and most anxiety disorders, so one medication can address both presentations. Dosing and how long a response takes may differ depending on which symptom cluster dominates.

Cognitive behavioral therapy applies to both as well, though the work looks different. Depression-focused CBT leans on behavioral activation and examining patterns of negative self-evaluation. Anxiety-focused CBT concentrates on avoidance and catastrophic prediction. When both conditions are present, therapy usually blends the two rather than running them in sequence.

“Which one should be treated first?”

Whichever one is doing more damage to daily functioning.

If anxiety has someone avoiding leaving the house, that needs attention before depression work becomes realistic. If depression has removed the motivation required to do anxiety exposure work, the order flips. This is a judgment call made per person, not a rule.

“Can treating one make the other worse?”

Temporarily, sometimes, and this catches people off guard badly enough that it is worth knowing in advance.

Starting an SSRI can produce a short period of increased anxiety before it produces improvement. Clinicians call this activation syndrome or jitteriness syndrome. It shows up as heightened anxiety, restlessness, agitation, insomnia, and a wired, nervous energy. It affects somewhere around 11 to 14 percent of people starting an SSRI, usually within the first one to four weeks, or after a dose increase.

The mechanism is fairly well understood. The initial rise in serotonin hits certain receptors that produce anxiety-like effects before those receptors adjust downward. It passes as the body adapts.

Risk is higher for people whose presentation is anxiety-dominant, people with panic disorder, younger patients, anyone starting at a higher dose, and anyone generally sensitive to medication. Which describes a lot of people in this comorbid group specifically.

Standard handling is starting at a low dose and increasing slowly. Sometimes a short-term bridging medication covers the adjustment window. The part that matters most is knowing it can happen, because people who are not warned often stop the medication in week two, convinced it is making things worse, when the effect was temporary and the drug was going to work.

“How long does treatment take when both are present?”

Longer than for either alone, and that is not a soft estimate, it is what the remission data shows.

Medication generally needs four to eight weeks at an adequate dose before anyone can judge whether it is working, and that timeline applies to the depressive symptoms. Anxiety symptoms sometimes respond on a different schedule, occasionally slower. Therapy operates on its own timeline depending on approach and frequency.

What this means practically is that two months in, with partial improvement and some symptoms still active, is not evidence of failure. It is a fairly typical point in the process. The harder version of this is that people with anxious depression are statistically less likely to reach full remission, which sometimes means the goal shifts toward substantial improvement and good management rather than complete symptom clearance.

“Do they both come back?”

They can, and the combination carries a higher relapse risk than either condition by itself.

Part of why is the untreated-half problem described earlier. Residual anxiety symptoms left after depression treatment raise the odds the depression returns. The same works in reverse.

This is a large part of the argument for treating both deliberately, and for not stopping treatment the moment things feel manageable. Maintenance decisions, meaning how long to stay on a medication or continue therapy after symptoms improve, are worth an explicit conversation with a provider rather than a unilateral decision made on a good week.

“What should I actually tell my provider?”

More than you think, and specifically the things that feel too small to mention.

Which symptom came first, historically. Not which one is worse now, which one showed up first, because that sequence shapes the clinical picture.

Whether anyone in your family has dealt with either condition. Given the shared 40 percent heritability, that history is more relevant than most people assume.

What the physical symptoms are doing, separately from the mood. Sleep, tension, appetite, energy.

What you have already tried, including things that partially worked. Partial response carries different information than no response.

And if a medication produced early side effects that made you stop, say so directly, including how long you took it. That distinction between a drug that did not work and a drug that was not given long enough to work changes the next decision considerably.

“Why do I feel better but not actually better?”

This is the question that brings a lot of people back in, and it usually has the same answer: only half the problem got treated.

Depression treatment lifts the mood. The worry, the physical tension, the avoidance, all still there. The person feels improved but not well, and the untreated anxiety frequently drags the depression back over time.

It runs the other direction too. Anxiety symptoms respond to treatment while an underlying depressive component keeps producing fatigue and flatness, which then gets misread as leftover anxiety instead of a separate condition needing separate attention.

A lot of people conclude from this that treatment does not work for them. More often, treatment worked on one of the two things they had.

What this looks like at Dare Therapy

Depression therapy and anxiety therapy at Dare Therapy are usually delivered together rather than as separate tracks, since the overlap described above is more common among people seeking care than either condition showing up alone. Evaluation covers both symptom clusters no matter which one brought someone in.

Cognitive behavioral therapy is a primary approach for this combination because its techniques transfer across both. Where symptoms are severe enough that therapy alone is unlikely to be enough, medication management runs alongside it.

Related reading: the different types of depression covers why the specific depressive presentation changes what treatment works, and why depression can feel like numbness instead of sadness describes a presentation anxiety often masks. On the anxiety side, why anxiety gets worse at night and why you might feel anxious for no reason both cover symptoms that show up frequently when depression is in the picture too.

This article is intended for general informational purposes only and does not constitute a diagnosis or medical advice. Depression and anxiety disorders can only be accurately diagnosed through evaluation by a licensed mental health professional. If you are experiencing thoughts of suicide or self-harm, please contact the 988 Suicide & Crisis Lifeline (call or text 988) or seek emergency care immediately.